Tovar V., Del Valle J., Zapater N., Martin M., Romero X., Pizcueta P., Bosch J., Terhorst C., Engel P.

Immunogenetics 54:394-402(2002) GeneRIF 4063 · UniProtKB (2) · Mapped (27)
Both mouse and human novel Ly9 genes mapped close to the CD229 gene in a region where other members of the CD150 family have also been mapped. GeneRIF 4063

Martin M., Del Valle J.M., Saborit I., Engel P.

J. Immunol. 174:5977-5986(2005) GeneRIF 4063 · Mapped (14)
CD229 but not other members of the CD150 family directly bind Grb2. GeneRIF 4063

Romero X., Zapater N., Calvo M., Kalko S.G., de la Fuente M.A., Tovar V., Ockeloen C., Pizcueta P., Engel P.

J. Immunol. 174:7033-7042(2005) GeneRIF 4063 · Mapped (18)
CD229 is a self-ligand interacting through its N-terminal V-like domain which contains three amino acid residues critical for the homophilic binding interaction. GeneRIF 4063

Cunninghame Graham D.S., Vyse T.J., Fortin P.R., Montpetit A., Cai Y.C., Lim S., McKenzie T., Farwell L., Rhodes B., Chad L. et al.

Genes Immun. 9:93-102(2008) GeneRIF 4063 · Mapped (10)
Observational study of gene-disease association. (HuGE Navigator); A family-based association study in the United Kingdom and Canada identifies genetic variants in the LY9 promoter and coding region contributing to systemic lupus erythematosus susceptibility. GeneRIF 4063

Davila S., Froeling F.E., Tan A., Bonnard C., Boland G.J., Snippe H., Hibberd M.L., Seielstad M.

Genes Immun. 11:232-238(2010) GeneRIF 4063 · Mapped (4,258)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 4063

Atanackovic D., Panse J., Hildebrandt Y., Jadczak A., Kobold S., Cao Y., Templin J., Meyer S., Reinhard H., Bartels K. et al.

Haematologica 96:1512-1520(2011) GeneRIF 4063 · Mapped (10)
CD229 is specifically over-expressed on myeloma cells including their clonogenic precursors and contributes to their malignant phenotype. GeneRIF 4063

Chatterjee M., Rauen T., Kis-Toth K., Kyttaris V.C., Hedrich C.M., Terhorst C., Tsokos G.C.

J. Immunol. 188:1206-1212(2012) GeneRIF 4063 · Mapped (13)
SLAMF3 and SLAMF6 T cell surface expression and IL-17 levels significantly correlate with disease activity in systemic lupus erythematosus patients GeneRIF 4063

Chatterjee M., Hedrich C.M., Rauen T., Ioannidis C., Terhorst C., Tsokos G.C.

J. Biol. Chem. 287:38168-38177(2012) GeneRIF 4063 · Mapped (25)
Data indicate that the dominance of the SLAMF3/SLAMF6 pathway in inducing IL-17A production can be attributed to an increased nuclear abundance and recruitment of RORgammat to the IL17A promoter. GeneRIF 4063